TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY

• 收藏
• 分享

专利权人:

发明人:

Faith NATHAN

申请号：

US15776732

公开号：

US20180371092A1

申请日:

2016.11.18

申请国别(地区):

US

年份:

2018

代理人:

摘要：

This disclosure provides a method for treating a subject afflicted with a lung cancer, which method comprises administering to the subject therapeutically effective amounts of: (a) an antibody or an antigen-binding portion thereof that specifically binds to a Programmed Death-1 (PD-1) receptor and inhibits PD-1 activity and (b) an antibody or an antigen-binding portion thereof that specifically binds to a Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) and inhibits CTLA-4 activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/